Sci Rep:西地那非和坦索罗辛响应的年龄相关差异是由于肌原性的平滑肌张力引起

2017-09-05 AlexYang MedSci原创

由于良性前列腺增生(BPH)的下尿路症状(LUTS)在老年人中高度流行,并且对病人的生活品质有着深远的影响。目前BPH/LUTS治疗方法以神经性平滑肌张力为治疗靶标,但是响应不可预测并且许多病人没有治疗响应。自发的血管肌源性收缩是平滑肌收缩的另一种组成,并且在人类前列腺中并未鉴定。为了更高的理解和改善病人响应的预测性,最近,研究人员利用人类前列腺标本明确了肌源性收缩,并且检测了已存在疗法的效应。研

由于良性前列腺增生(BPH)的下尿路症状(LUTS)在老年人中高度流行,并且对病人的生活品质有着深远的影响。目前BPH/LUTS治疗方法以神经性平滑肌张力为治疗靶标,但是响应不可预测并且许多病人没有治疗响应。自发的血管肌源性收缩是平滑肌收缩的另一种组成,并且在人类前列腺中并未鉴定。为了更高的理解和改善病人响应的预测性,最近,研究人员利用人类前列腺标本明确了肌源性收缩,并且检测了已存在疗法的效应。

研究发现,肌源性活性在人类前列腺中是存在的,并且在来自诊断为BPH病人的转变区样本中收缩频率大约是匹配对照的160%。α1-肾上腺受体拮抗剂(坦索罗辛)和PDE5抑制剂(西地那非)均显著的减少了肌源性的收缩参数,包括频率,并且具有明显的病人间的多态性。另外,坦索罗辛在老年病人中(R2?=?0.36, p?<?0.01)以及具有更大前列腺体积男性中(R2?=?0.41, p?<?0.05)更加有效,然而西地那非在年轻男性中更加有效(R2?=?0.45, p?<?0.05)。由于血管肌源性收缩在BPH中显著增加,利用该机制的靶标疗法并且参考病人特性,能够改善临床结果并且更好的预测病人响应。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1933423, encodeId=652719334232b, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Nov 22 08:36:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986766, encodeId=6d591986e6647, content=<a href='/topic/show?id=ce884149923' target=_blank style='color:#2F92EE;'>#坦索罗辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41499, encryptionId=ce884149923, topicName=坦索罗辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Oct 06 09:36:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774740, encodeId=0a8e1e7474081, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Dec 26 01:36:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691691, encodeId=53a61691691b6, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Sun Jan 07 03:36:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540577, encodeId=15aa15405e7d0, content=<a href='/topic/show?id=fa348091883' target=_blank style='color:#2F92EE;'>#肌张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80918, encryptionId=fa348091883, topicName=肌张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=524213265654, createdName=gujh, createdTime=Thu Sep 07 10:36:00 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1933423, encodeId=652719334232b, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Nov 22 08:36:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986766, encodeId=6d591986e6647, content=<a href='/topic/show?id=ce884149923' target=_blank style='color:#2F92EE;'>#坦索罗辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41499, encryptionId=ce884149923, topicName=坦索罗辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Oct 06 09:36:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774740, encodeId=0a8e1e7474081, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Dec 26 01:36:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691691, encodeId=53a61691691b6, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Sun Jan 07 03:36:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540577, encodeId=15aa15405e7d0, content=<a href='/topic/show?id=fa348091883' target=_blank style='color:#2F92EE;'>#肌张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80918, encryptionId=fa348091883, topicName=肌张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=524213265654, createdName=gujh, createdTime=Thu Sep 07 10:36:00 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1933423, encodeId=652719334232b, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Nov 22 08:36:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986766, encodeId=6d591986e6647, content=<a href='/topic/show?id=ce884149923' target=_blank style='color:#2F92EE;'>#坦索罗辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41499, encryptionId=ce884149923, topicName=坦索罗辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Oct 06 09:36:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774740, encodeId=0a8e1e7474081, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Dec 26 01:36:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691691, encodeId=53a61691691b6, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Sun Jan 07 03:36:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540577, encodeId=15aa15405e7d0, content=<a href='/topic/show?id=fa348091883' target=_blank style='color:#2F92EE;'>#肌张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80918, encryptionId=fa348091883, topicName=肌张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=524213265654, createdName=gujh, createdTime=Thu Sep 07 10:36:00 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
    2017-12-26 zhmscau
  4. [GetPortalCommentsPageByObjectIdResponse(id=1933423, encodeId=652719334232b, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Nov 22 08:36:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986766, encodeId=6d591986e6647, content=<a href='/topic/show?id=ce884149923' target=_blank style='color:#2F92EE;'>#坦索罗辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41499, encryptionId=ce884149923, topicName=坦索罗辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Oct 06 09:36:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774740, encodeId=0a8e1e7474081, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Dec 26 01:36:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691691, encodeId=53a61691691b6, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Sun Jan 07 03:36:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540577, encodeId=15aa15405e7d0, content=<a href='/topic/show?id=fa348091883' target=_blank style='color:#2F92EE;'>#肌张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80918, encryptionId=fa348091883, topicName=肌张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=524213265654, createdName=gujh, createdTime=Thu Sep 07 10:36:00 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1933423, encodeId=652719334232b, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Nov 22 08:36:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986766, encodeId=6d591986e6647, content=<a href='/topic/show?id=ce884149923' target=_blank style='color:#2F92EE;'>#坦索罗辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41499, encryptionId=ce884149923, topicName=坦索罗辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Oct 06 09:36:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774740, encodeId=0a8e1e7474081, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Dec 26 01:36:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691691, encodeId=53a61691691b6, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Sun Jan 07 03:36:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540577, encodeId=15aa15405e7d0, content=<a href='/topic/show?id=fa348091883' target=_blank style='color:#2F92EE;'>#肌张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80918, encryptionId=fa348091883, topicName=肌张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=524213265654, createdName=gujh, createdTime=Thu Sep 07 10:36:00 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
    2017-09-07 gujh

相关资讯

儿科药物研发的机遇与挑战:来自西地那非的启示

美国食品药品监督管理局(FDA)基于西地那非治疗儿童肺动脉高压的相关研究,批准了其相关适应证,对儿科药物研发带来一系列启发。作者将这些启发书成文并于2017年7月发表在了《J Am Coll Cardiol》上。

药监局警告:凡是”改善男性性功能“的保健食品都违法

。国家食品药品监督管理总局(CFDA)5月13日为此发文称,食品或保健食品等中添加西地那非属违法行为,凡已批准注册的保健食品宣传“改善男性性功能”均属虚假宣传。

Obstet Gynecol:枸橼酸西地那非治疗羊水过少

由此可见,枸橼酸西地那非增加了妊娠合并羊水过少患者的羊水体积。

JCEM:治疗勃起功能障碍的药物或可用于预防糖尿病的发生

JCEM:治疗勃起功能障碍的药物或可用于预防糖尿病的发生据发表于《临床内分泌代谢杂志》的一项新的研究表明,西地那非,即我们所熟知的伟哥或其他治疗勃起功能障碍药物的有效成分,可提高易患糖尿病人群的胰岛素敏感性。西地那非可抑制磷酸二酯酶5(PDE5),导致平滑肌松弛,血管扩张,血流量增加,它常用于治疗男性勃起功能障碍,还可用于治疗肺动脉高压。动物研究表明,西地那非可改善机体的胰岛素敏感性,提高其从血液

BMJ:继发于西地那非治疗后的视网膜静脉阻塞 -案例报道

没有发现特殊的原因,但进一步的问诊显示该患者经常服用西地那非治疗勃起功能障碍。西地那非已知的副作用是引起视网膜血管阻塞。

J Clin Endocrinol Metab:PDE5抑制剂可改善糖尿病前期患者胰岛素敏感性

一项新的研究发现勃起功能障碍药物西地那非(伟哥)改善糖尿病前期患者的胰岛素敏感性和内皮功能标志物状态。研究结果11月18日在线发表在Journal of Clinical Endocrinology and Metabolism。